The discrimination power and accuracy of NF-L for distinguishing individuals with PD from those with other Parkinsonian disorders increase substantially when combined with amyloid β42 (Aβ42), phosphorylated tau (p-tau), total tau, and total α-synuclein (α-syn) in CSF [105]. This evidence concerns the gene MAPT and parkinsonian disorder.